Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Sudden cardiac death/sudden cardiac arrest (SCD/SCA) is an increasingly prevalent cause of mortality globally, particularly in individuals with preexisting cardiac conditions. The ambiguous premortem warnings and the restricted interventional window related to SCD account for the complexity of the condition. Current reports suggest SCD to be accountable for 20% of all deaths hence accurately predicting SCD risk is an imminent concern. Traditional approaches for predicting SCA, particularly “track-and-trigger” warning systems have demonstrated considerable inadequacies, including low sensitivity, false alarms, decreased diagnostic liability, reliance on clinician involvement, and human errors. Artificial intelligence (AI) and machine learning (ML) models have demonstrated near-perfect accuracy in predicting SCA risk, allowing clinicians to intervene timely. Given the constraints of current diagnostics, exploring the benefits of AI and ML models in enhancing outcomes for SCA/SCD is imperative. This review article aims to investigate the efficacy of AI and ML models in predicting and managing SCD, particularly targeting accuracy in prediction.
Sudden cardiac death/sudden cardiac arrest (SCD/SCA) is an increasingly prevalent cause of mortality globally, particularly in individuals with preexisting cardiac conditions. The ambiguous premortem warnings and the restricted interventional window related to SCD account for the complexity of the condition. Current reports suggest SCD to be accountable for 20% of all deaths hence accurately predicting SCD risk is an imminent concern. Traditional approaches for predicting SCA, particularly “track-and-trigger” warning systems have demonstrated considerable inadequacies, including low sensitivity, false alarms, decreased diagnostic liability, reliance on clinician involvement, and human errors. Artificial intelligence (AI) and machine learning (ML) models have demonstrated near-perfect accuracy in predicting SCA risk, allowing clinicians to intervene timely. Given the constraints of current diagnostics, exploring the benefits of AI and ML models in enhancing outcomes for SCA/SCD is imperative. This review article aims to investigate the efficacy of AI and ML models in predicting and managing SCD, particularly targeting accuracy in prediction.
Being an extremely high mortality rate condition, cardiac arrest cases have rightfully been evaluated via various studies and scoring factors for effective resuscitative practices and neurological outcomes post resuscitation. This narrative review aims to explore the role of Artificial Intelligence (AI) in predicting neurological outcomes post cardiac resuscitation. Methodology involved detailed review of all relevant recent studies of AI, different machine learning algorithms, prediction tools and assessing their benefit in predicting neurological outcomes in post cardiac resuscitation cases as compared to more traditional prognostic scoring systems and tools. Previously, outcome determining clinical, blood and radiological factors were prone to other influencing factors like limited accuracy and time constraints. Studies conducted also emphasized that to predict poor neurological outcomes, a more multimodal approach helped adjust for confounding factors, interpret diverse datasets and provide a reliable prognosis which only demonstrates need for AI to help overcome challenges faced. Advanced machine learning algorithms like Artificial Neural Networks (ANN) using supervised learning by AI have improved accuracy of prognostic models outperforming conventional models. Several real-world cases of effective AI powered algorithm models have been cited here. Studies comparing machine learning tools like XGBoost, AI Watson, hyperspectral imaging, ChatGPT-4 and AI based gradient boosting have noted their beneficial uses. AI could help reduce workload, healthcare costs and help personalize care, process vast genetic and lifestyle data and help reduce side effects from treatments. Limitations of AI have been covered extensively in this article including data quality, bias, privacy issues and transparency. Our objectives should be to use more diverse data sources, use interpretable data output giving process explanation, validation method and implement policies to safeguard patient data. Despite the limitations, the advancements already made by AI and its potential in predicting neurological outcomes in post cardiac resuscitation cases has been quite promising and boosts a continually improving system, albeit requiring close human supervision with training and improving models, with plans to educate clinicians, the public and sharing collected data.
Artificial intelligence (AI) holds immense promise for revolutionizing emergency medicine, expediting diagnosis and treatment decisions. This review explores AI’s wide-ranging applications in emergency care, ranging from managing out-of-hospital cardiac arrest (OHCA) to diagnosing fractures, spine injuries, stroke, and pulmonary embolisms, and even assisting in search and rescue missions with snake robots. In OHCA cases, AI aids in early detection, survival prediction, and ECG waveform classification, bolstering prehospital care efficiency. AI-powered digital assistants like the AI4EMS platform optimize diagnosis and patient prioritization, reducing overlooked cases of cardiac arrest and improving response times. Furthermore, AI algorithms enhance the diagnosis of conditions such as pneumothorax, pulmonary emphysema, and fractures by analysing medical images with exceptional accuracy, often outperforming human experts. In stroke and pulmonary embolism, AI expedites diagnosis through automated imaging analysis, enabling swift treatment. AI may enhance triage methods with independent systems, improving patient sharing and treatment quality while minimizing infection risks, especially during pandemics. Medical professionals generally welcome AI triage systems, acknowledging their potential to enhance healthcare efficiency. It is important to understand the scope of development of AI in order to make its application beneficial.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.